CompletedNCT04344639

Incidence, Risk Factors, Severity and Prognosis of Necrotizing Enterocolitis in Turkey

Studying Necrotizing enterocolitis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Turkish Neonatal Society
Principal Investigator
Tolga H Çelik, MD, M.D
Hacettepe University Faculty of Medicine Department of Pediatrics
Intervention
the incidence, risk factors, treatment, prognosis of necrotizing enterocolitis in newborn infants born in newborn intensive care units in our country(other)
Enrollment
500 enrolled
Eligibility
All sexes
Timeline
2019 – 2020

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04344639 on ClinicalTrials.gov

Other trials for Necrotizing enterocolitis

Additional recruiting or active studies for the same condition.

See all trials for Necrotizing enterocolitis →

← Back to all trials